Cancer Pain Treatment

This page contains recent news articles, when available, and an overview of Cancer Pain Treatment but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.

News: Cancer Pain Treatment

Peer review journal publishes encouraging study results for GW Pharmaceuticals ...  -  23 Nov 2009
Behavioral Health Central (blog)23 November 2009 - UK-based cannabinoid pharmaceutical products developer GW Pharmaceuticals plc (LON: GPW) said today that results from a study of Sativex ...

The Cancer Pain Drug Market, Driven by the Continued Dominance of Opioids ...  -  ‎Nov 17, 2009‎
PR Newswire (press release)...availability and physician familiarity, older opioids such as immediate-release morphine will continue to dominate breakthrough cancer pain treatment. ...

Pain Care to Improve Quality of Life for the Diseased and the Distressed  -  ‎Oct 30, 2009‎
MedIndiaIn fact, a country's development in palliative care is measured by the increased use of oral morphine in cancer pain treatment. ...

BioDelivery Sciences posts $2.6 million loss for the quarter  -  ‎Nov 6, 2009‎
Bizjournals.comThe company has received FDA approval for its Onsolis cancer pain treatment for people aged 18 and older who are opiod tolerant. That approval triggered a ...

The Wait Is Over For BioDelivery Sciences – Stocks To Watch  -  ‎Jul 17, 2009‎
RTT NewsThe current market leaders in cancer pain treatment are Fentora and Actiq, both manufactured by Cephalon Inc. (CEPH). Like Fentora and Actiq, Onsolis also

Abstral to be released in France for cancer pain management  -  ‎Jul 11, 2009‎
Mesothelioma NewsA new cancer pain treatment drug, Abstral, will be released in France this month by the pharmaceutical company ProStrakan Group.

Genetic variation in the Catechol-O-Methyltransferase (COMT) gene ...  -  Dec 18, 2008
7thSpace Interactive (press release),Rs4680 (Val158Met), influence pain sensitivity in human experimental pain and the efficacy for morphine in cancer pain treatment.

Gerard Manecke, MD, Appointed Chair of Anesthesiology for UC San ...  -  Nov 3, 2008
UCSD Medical Center,...acute and chronic pain including cancer pain. Treatment methods include pharmacological options as well as diverse approaches such as physical therapy,

‘Positive opinion’ helps ProStrakan shares to soar  -  Jun 27, 2008
The Herald,...almost 3% after the Borders-based specialist drug company said it had received a "positive opinion" in Europe for its Abstral cancer-pain treatment.

Advisory Panel for European Regulatory Board Weighs In Positively ...  -  Jun 27, 2008
Genetic Engineering News (press release),ProStrakan in-licensed exclusive European rights to the cancer pain treatment Abstral from Orexo. Abstral is a fast-dissolving tablet for sublingual

Friday's company news summary  -  Mar 7, 2008
Investors Chronicle,Speciality pharmaceutical company Prostrakan inched higher Friday on news it has received marketing authorisation in Sweden for cancer pain treatment

Sosei initiates Phase III studies for cancer pain treatment  -  13 Feb 2008
Pharmaceutical Business ReviewBy Staff Writer The trial is a multi-centre, randomized, double-blind, double-dummy, crossover study to evaluate the safety and efficacy of fentanyl

CeNeS Pharmaceuticals Gains on Takeover Approach (Update1)  -  Feb 5, 2008
BloombergThe drugmaker also is developing the cancer pain treatment CNS 5161, which is in human trials, and the sedative CNS 7056, which is in pre-clinical

CeNeS in bid talks  -  Feb 5, 2008 (subscription),AIM-quoted CeNeS, headed by chief executive officer Neil Clark, has another product, its CNS 5161 cancer pain treatment, in Phase II trials at the moment.

Endo:Cancer Pain Drug Effective in Study  -  Dec 17, 2007
Motley FoolBy AP December 17, 2007 Endo Pharmaceuticals Inc. said Monday an interim analysis of late-stage clinical data showed its cancer pain treatment candidate

Minority Women More Likely to Experience Severe Pain Related to ...  -  Nov 28, 2007
Medscape (subscription)...the medical profession in general has an obligation to determine the scope of cancer pain treatment disparities and to devise remedies that address it.

The CyberKnife: A New Cancer Treatment At Roper St. Francis  -  Dec 4, 2007
Live 5 News,New hope for cancer patients who were told surgery would never work. A new robot at Roper St. Francis Hospital is giving doctors a new non-invasive way to

China Aoxing Pharmaceutical Designated As A Key Manufacturer Of  -  Nov 26, 2007
Pharmaceutical Online (press release),China's government and medical community are fully aware that China is woefully behind the rest of world in cancer pain treatment.

Background information on Cancer Pain Treatment [When available]

Cancer treatment information from the National Cancer Institute

Search the web for more resources on Cancer Pain Treatment

Health Home | Conditions | Cancer | Medications | Surgery | Vaccines

The Cancer News Network


Contact a physician with regard to health concerns. Email requests for further health information will be discarded.

The materials contained on this Web site are for informational purposes only and do not constitute health or medical advice. Use of information on this site does not create or constitute any kind of agreement or contract between you and the owners or users of this site, the owners of the servers upon which it is housed, or anyone else who is in any way connected with this site.

Many links on lead to other sites. does not sponsor, endorse or otherwise approve of the materials appearing in such sites. Nor is responsible for dead or misdirected links.

We will do our best to accommodate your request.